Back

Safety, diagnostic yield and clinical utility of endomyocardial biopsy in patients with suspected cardiac amyloidosis: a 10-year consecutive single-centre experience

28 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Diagnosis and risk stratification in cardiac amyloidosis Infiltrative Myocardial Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Josephine Mansell

National Amyloidosis Centre, London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Lymphocyte-to–C-reactive-protein ratio is a strong predictor of mortality risk in cardiac transthyretin amyloidosis
Mr V. Cejka (Wurzburg, DE)
Abstract Slides Video
Presentation thumbnail
Idiopathic carpal tunnel syndrome as an early clinical indicator of transthyretin cardiac amyloidosis: diagnostic insights
Doctor E. Martins (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Transthyretin gene variants in a population-based study of 9,957 Finnish men and in 366 Finnish patients with hypertrophic cardiomyopathy
Doctor T. Pennanen (Kuopio, FI)
Abstract Slides Video
Presentation thumbnail
Ventricular arrhythmias in ATTR-CM: frequency, disease severity and risk of sudden cardiac death
Doctor K. Knoll (Munich, DE)
Abstract Slides Video
Presentation thumbnail
AI-guided population screening for cardiac ATTR amyloidosis in heart failure patients within ambulatory health service's database
Doctor I. Davarashvili (Jerusalem, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Diagnosis and risk stratification in cardiac amyloidosis

The Event

Event poster

ESC Congress 2026

28 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
When imaging is not enough: diagnostic performance of endomyocardial biopsy in cardiac amyloidosis
11 May 2026
thumbnail
Congress Presentation
Evolution of echocardiographic parameters during tafamidis therapy in patients with transthyretin cardiac amyloidosis: a real-world cohort study
30 August 2026
thumbnail
Congress Presentation
Catheter ablation for atrial fibrillation in patients with cardiac amyloidosis - Clinical characteristics and outcomes
13 April 2026
thumbnail
Congress Presentation
A review of routine bone scintigraphy reports for identification of incidental myocardial tracer uptake indicating cardiac amyloidosis
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources